Therefore, with support from the discussion above, we hypothesized that HDAC11 could be a novel inflammatory biomarker in HD because it directly inhibits the expression of IL-10 (acting as an anti-inflammatory marker) and leads to inflammation that continues to lead to the development of Huntington's disease. The gene discussed is IL10; the disease is Huntington disease.